SCHEMBL4529041

SCHEMBL4529041

COC(=N)C1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4525843 0.98
SCHEMBL20742424 0.86
SCHEMBL3204554 0.82
Hydrochloric Acid SCHEMBL717963 0.79
SCHEMBL21449654 0.76 TSHR (0.37)
SCHEMBL909692 0.75 NOS2 (0.42)
Hydrochloric Acid SCHEMBL20819822 0.75 NOS2 (0.42)
Hydrochloric Acid SCHEMBL14333624 0.74 TSHR (0.36)
Hydrochloric Acid SCHEMBL4532413 0.73 NOS2 (0.40)
SCHEMBL18652824 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314121-B2 Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7 SANOFI (FR) 2012-11-20 US disclosed
US-20090253679-A1 NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 SANOFI-AVENTIS (FR) 2009-10-08 US disclosed